DR. RAYMOND PAUL WARRELL, M.D.
Osteopathic Medicine at Kimball Cir, Westfield, NJ
License number
New Jersey 130599
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
6 Kimball Cir, Westfield, NJ 07090
Phone
(908) 286-3965
(908) 464-1705 (Fax)
(908) 464-1705 (Fax)
Personal information
See more information about RAYMOND PAUL WARRELL at radaris.comName
Address
Phone
6 Kimball Cir, Westfield, NJ 07090
Westfield, NJ
6 Kimball Ave, Westfield, NJ 07090
837 East St, Bay Head, NJ 08738
837 East Ave, Point Pleasant Beach, NJ 08742
Professional information
Dr. Raymond P Warrell, Westfield NJ - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
6 Kimball Cir, Westfield 07090
(908) 286-3965 (Phone), (908) 464-1705 (Fax)
GENTA INC
200 Connell Dr SUITE 43H, Berkeley Heights 07922
(908) 286-9800 (Phone), (908) 464-1701 (Fax)
(908) 286-3965 (Phone), (908) 464-1705 (Fax)
GENTA INC
200 Connell Dr SUITE 43H, Berkeley Heights 07922
(908) 286-9800 (Phone), (908) 464-1701 (Fax)
Certifications:
Internal Medicine, 1978, Medical Oncology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Medical College of Georgia
Graduated: 1975
SUNY Stony Brook Affil Hosp
Sloan-Kettering Cancer Ctr
Medical College of Georgia
Graduated: 1975
SUNY Stony Brook Affil Hosp
Sloan-Kettering Cancer Ctr
Dr. Raymond P Warrell, Westfield NJ - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
6 Kimball Cir, Westfield 07090
(908) 286-3965 (Phone), (908) 464-1705 (Fax)
(908) 286-3965 (Phone), (908) 464-1705 (Fax)
Languages:
English
Methods Of Treatment Of A Bcl-2 Disorder Using Bcl-2 Antisense Oligomers
US Patent:
2005003, Feb 10, 2005
Filed:
Dec 16, 2003
Appl. No.:
10/738867
Inventors:
Raymond Warrell - Westfield NJ, US
International Classification:
A61K048/00, A61K031/7048, A61K031/28
US Classification:
514027000, 514044000, 514492000
Abstract:
The present invention is directed to the use of bcl-2 antisense oligomers to treat and prevent bcl-2 related disorders. These disorders include cancers, tumors, carcinomas and cell-proliferative related disorders. In one embodiment of the invention, a bcl-2 antisense oligomer is administered at high doses. The present invention is also directed to a method of preventing or treating a bcl-2 related disorder, in particular cancer, comprising administering a bcl-2 antisense oligomer for short periods of time. The present invention is further drawn to the use of bcl-2 antisense oligomers to increase the sensitivity of a subject to cancer therapeutics. The present invention also relates to pharmaceutical compositions comprising one or more bcl-2 antisense oligomers, which may comprise one or more cancer therapeutic agents.
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2006002, Feb 9, 2006
Filed:
Sep 30, 2005
Appl. No.:
11/239704
Inventors:
Raymond Warrell - Westfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
A61K 33/36, A61K 31/203
US Classification:
424623000, 514559000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Use Of Inhaled Retinoids In The Prevention Of Cancer
US Patent:
6251941, Jun 26, 2001
Filed:
Dec 29, 1998
Appl. No.:
9/171478
Inventors:
William P. Tong - Flushing NY
Raymond P. Warrell - Westfield NJ
Raymond P. Warrell - Westfield NJ
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A01N 3700, A61K 3120
US Classification:
514559
Abstract:
Administration of retinoids by inhalation is used to overcome the chronic toxicity problems presented by systemic administration and to make retinoid therapy available as an option for the prevention of epithelial cancers of the respiratory tract, especially those that are associated with tobacco use. Retinoids are administered by inhalation to the respiratory tract of the individual as an air-borne composition with a metered dose aerosol-producing inhaler, in which the retinoid is dissolved in a combination of a pharmaceutically acceptable chlorofluorocarbon propellant and an alkylamine solubilizing agent.
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2004014, Jul 29, 2004
Filed:
Jan 16, 2004
Appl. No.:
10/758995
Inventors:
Raymond Warrell - Westfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
A61K033/36
US Classification:
424/623000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2004014, Jul 29, 2004
Filed:
Jan 16, 2004
Appl. No.:
10/758996
Inventors:
Raymond Warrell - Westfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
A61K033/36
US Classification:
424/623000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2004014, Jul 29, 2004
Filed:
Jan 16, 2004
Appl. No.:
10/759657
Inventors:
Raymond Warrell - Westfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
A61K033/36
US Classification:
424/623000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Tri(Alkylcarboxylato)Gallium (Iii) Products And Pharmaceutical Compositions Containing Them
US Patent:
2005026, Nov 24, 2005
Filed:
Sep 22, 2003
Appl. No.:
10/668473
Inventors:
Jack Jiang - Orange Village OH, US
Raymond Warrell - Westfield NJ, US
Kollengode Ramaswamy - Farmington CT, US
Robert Klem - Rancho Santa Fe CA, US
Raymond Warrell - Westfield NJ, US
Kollengode Ramaswamy - Farmington CT, US
Robert Klem - Rancho Santa Fe CA, US
International Classification:
A61K031/28, C07F005/00
US Classification:
514492000, 556001000
Abstract:
Provided are novel tri(alkylcarboxylato) gallium (III) compounds, exemplified by tripalmitato gallium (III), methods for making them, pharmaceutical compositions containing them, and methods of using the pharmaceutical compositions.
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2004014, Jul 29, 2004
Filed:
Jan 16, 2004
Appl. No.:
10/759439
Inventors:
Raymond Warrell - Westfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
A61K033/36
US Classification:
424/623000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.